Literature DB >> 35311247

Microbiological characteristics of bacteremias among COVID-19 hospitalized patients in a tertiary referral hospital in Northern Greece during the second epidemic wave.

Efthymia Protonotariou1, Paraskevi Mantzana1, Georgios Meletis1, Areti Tychala1, Angeliki Kassomenaki1, Olga Vasilaki1, Georgia Kagkalou1, Ioanna Gkeka1, Maria Archonti1, Styliani Kati2, Simeon Metallidis2, Lemonia Skoura1.   

Abstract

Northern Greece was struck by an intense second COVID-19 (coronavirus disease 2019) epidemic wave during the fall of 2020. Because of the coinciding silent epidemic of multidrug-resistant organisms, the handling of COVID-19 patients became even more challenging. In the present study, the microbiological characteristics of bacteremias in confirmed cases of hospitalized COVID-19 patients were determined. Data from 1165 patients hospitalized between September and December 2020 were reviewed regarding the frequency of bloodstream infections, the epidemiology and the antibiotic susceptibility profiles of the causative bacteria. The hospital's antibiotic susceptibility data for all major nosocomial pathogens isolated from bacteremias of COVID-19 patients between September and December 2020 versus those between September and December 2019 were also compared. Overall, 122 patients developed bacteremia (10.47%). The average of time interval between hospitalization date and development of bacteremia was 13.98 days. Admission to ICU occurred in 98 out of 122 patients with an average stay time of 15.85 days and 90.81% in-hospital mortality. In total, 166 pathogens were recovered including 114 Gram-negative bacteria and 52 Gram-positive cocci. Acinetobacter baumannii was the most frequent (n = 51) followed by Klebsiella pneumoniae (n = 45) and Enterococcus faecium (n = 31). Bacteremias in hospitalized COVID-19 patients were related with prolonged time of hospitalization and higher in-hospital mortality, and the isolated microorganisms represented the bacterial species that were present in our hospital before the COVID-19 pandemic. Worryingly, the antibiotic resistance rates were increased compared with the pre-pandemic era for all major opportunistic bacterial pathogens. The pandemic highlighted the need for continuous surveillance of patients with prolonged hospitalization.
© The Author(s) 2021. Published by Oxford University Press on behalf of FEMS.

Entities:  

Keywords:  COVID-19; bacteremia; coinfection

Year:  2021        PMID: 35311247      PMCID: PMC8847882          DOI: 10.1093/femsmc/xtab021

Source DB:  PubMed          Journal:  FEMS Microbes        ISSN: 2633-6685


  26 in total

1.  Evaluation of the "AMR Direct Flow Chip Kit" DNA microarray for detecting antimicrobial resistance genes directly from rectal and nasopharyngeal clinical samples upon ICU admission.

Authors:  Efthymia Protonotariou; Georgios Meletis; Dimitra Papadopoulou; Melania Kachrimanidou; Lilian Toptsi; Lemonia Skoura
Journal:  Enferm Infecc Microbiol Clin (Engl Ed)       Date:  2021 Jun-Jul

2.  A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates.

Authors:  Athanassios Tsakris; Aggeliki Poulou; Spyros Pournaras; Evangelia Voulgari; Georgia Vrioni; Katerina Themeli-Digalaki; Dimitra Petropoulou; Danai Sofianou
Journal:  J Antimicrob Chemother       Date:  2010-06-11       Impact factor: 5.790

Review 3.  The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.

Authors:  Chandini Raina MacIntyre; Abrar Ahmad Chughtai; Michelle Barnes; Iman Ridda; Holly Seale; Renin Toms; Anita Heywood
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

4.  Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital.

Authors:  Angela Gomez-Simmonds; Medini K Annavajhala; Thomas H McConville; Donald E Dietz; Sherif M Shoucri; Justin C Laracy; Felix D Rozenberg; Brian Nelson; William G Greendyke; E Yoko Furuya; Susan Whittier; Anne-Catrin Uhlemann
Journal:  J Antimicrob Chemother       Date:  2021-01-19       Impact factor: 5.790

5.  Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome.

Authors:  Tommaso Bardi; Vicente Pintado; Maria Gomez-Rojo; Rosa Escudero-Sanchez; Amal Azzam Lopez; Yolanda Diez-Remesal; Nilda Martinez Castro; Patricia Ruiz-Garbajosa; David Pestaña
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-03       Impact factor: 3.267

6.  Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies.

Authors:  Akshay Khatri; Prashant Malhotra; Stephanie Izard; Angela Kim; Michael Oppenheim; Pranisha Gautam-Goyal; Thomas Chen; Thien-Ly Doan; Ilan Berlinrut; Negin Niknam; Sarah Flannery; David Hirschwerk; Marcia Epstein; Bruce Farber
Journal:  Open Forum Infect Dis       Date:  2021-06-30       Impact factor: 3.835

7.  Characterization of Secondary Bacterial Infections and Antibiotic Use in Mechanically Ventilated Patients With COVID-19 Induced Acute Respiratory Distress Syndrome.

Authors:  Erik Risa; David Roach; Jehan Z Budak; Christopher Hebert; Jeannie D Chan; Nandita S Mani; Chloe Bryson-Cahn; James Town; Nicholas J Johnson
Journal:  J Intensive Care Med       Date:  2021-08-10       Impact factor: 3.510

View more
  1 in total

1.  Bloodstream Infections in a COVID-19 Non-ICU Department: Microbial Epidemiology, Resistance Profiles and Comparative Analysis of Risk Factors and Patients' Outcome.

Authors:  Efthymia Giannitsioti; Christina Louka; Vasiliki Mamali; Elisavet Kousouli; Lemonia Velentza; Vaia Papadouli; Georgios Loizos; Panagiotis Mavroudis; Georgios Kranidiotis; Nektaria Rekleiti; Alexandra Stamati; Ioannis Speggos; Ioannis Daniil; Panagiotis Kouvatsos; Chrysanthi Sidiropoulou; Garifallia Linardaki; Styliani Gerakari; Georgios Chrysos; Katina Themeli-Digalaki; Olympia Zarkotou
Journal:  Microorganisms       Date:  2022-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.